To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

NCT02318303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1111

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: GSP 301-1 NS (QD)
DRUG: GSP 301-2 NS (BID)
DRUG: GSP 301 Placebo NS
DRUG: Olopatadine HCl-1 NS (QD)
DRUG: Olopatadine HCl-2 NS (BID)
DRUG: Mometasone Furoate-1 NS (QD)
DRUG: Mometasone Furoate-2 NS (BID)

Sponsor

Glenmark Pharmaceuticals Ltd. India